523 related articles for article (PubMed ID: 31965935)
1. Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy.
Zhu S; Yu Q; Huo C; Li Y; He L; Ran B; Chen J; Li Y; Liu W
Curr Med Chem; 2021; 28(2):329-345. PubMed ID: 31965935
[TBL] [Abstract][Full Text] [Related]
2. The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer.
Hu Y; Guo N; Yang T; Yan J; Wang W; Li X
Oxid Med Cell Longev; 2022; 2022():1458143. PubMed ID: 35028002
[TBL] [Abstract][Full Text] [Related]
3. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells.
Ooko E; Saeed ME; Kadioglu O; Sarvi S; Colak M; Elmasaoudi K; Janah R; Greten HJ; Efferth T
Phytomedicine; 2015 Oct; 22(11):1045-54. PubMed ID: 26407947
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment.
Li D; Zhang J; Zhao X
Cancer Invest; 2021 Sep; 39(8):675-684. PubMed ID: 34241563
[TBL] [Abstract][Full Text] [Related]
5. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis.
Chen GQ; Benthani FA; Wu J; Liang D; Bian ZX; Jiang X
Cell Death Differ; 2020 Jan; 27(1):242-254. PubMed ID: 31114026
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Activity of Artemisinin and its Derivatives.
Slezakova S; Ruda-Kucerova J
Anticancer Res; 2017 Nov; 37(11):5995-6003. PubMed ID: 29061778
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive overview of Artemisinin and its derivatives as anticancer agents.
Zeng ZW; Chen D; Chen L; He B; Li Y
Eur J Med Chem; 2023 Feb; 247():115000. PubMed ID: 36538859
[TBL] [Abstract][Full Text] [Related]
8. Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment.
Kumar MS; Yadav TT; Khair RR; Peters GJ; Yergeri MC
Curr Pharm Des; 2019; 25(31):3323-3338. PubMed ID: 31475891
[TBL] [Abstract][Full Text] [Related]
9. The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers.
Zhang S; Yi C; Li WW; Luo Y; Wu YZ; Ling HB
Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200086. PubMed ID: 35484335
[TBL] [Abstract][Full Text] [Related]
10. GPX4 inhibition synergistically boosts mitochondria targeting nanoartemisinin-induced apoptosis/ferroptosis combination cancer therapy.
Yu H; Li JM; Deng K; Zhou W; Li KH; Wang CX; Wang Q; Wu M; Huang SW
Biomater Sci; 2023 Aug; 11(17):5831-5845. PubMed ID: 37439624
[TBL] [Abstract][Full Text] [Related]
11. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.
Nakase I; Lai H; Singh NP; Sasaki T
Int J Pharm; 2008 Apr; 354(1-2):28-33. PubMed ID: 17942255
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.
Li Y; Zhou X; Liu J; Yuan X; He Q
Anticancer Agents Med Chem; 2020; 20(5):520-535. PubMed ID: 31958040
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Artemisinin Hybrids Induce Apoptosis and Ferroptosis in MCF-7 Cells.
Zhong Y; Li ZN; Jiang XY; Tian X; Deng MH; Cheng MS; Yang HL; Liu Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555409
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?
Li Z; Li Q; Wu J; Wang M; Yu J
Molecules; 2016 Oct; 21(10):. PubMed ID: 27739410
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of the pH- and Oxygen-Dependent Oxidation Activities of Artesunate.
Tsuda K; Miyamoto L; Hamano S; Morimoto Y; Kangawa Y; Fukue C; Kagawa Y; Horinouchi Y; Xu W; Ikeda Y; Tamaki T; Tsuchiya K
Biol Pharm Bull; 2018; 41(4):555-563. PubMed ID: 29607928
[TBL] [Abstract][Full Text] [Related]
16. Biological Activities of Artemisinin Derivatives Beyond Malaria.
Liu X; Cao J; Huang G; Zhao Q; Shen J
Curr Top Med Chem; 2019; 19(3):205-222. PubMed ID: 30674260
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis plays an essential role in the antimalarial mechanism of low-dose dihydroartemisinin.
Li S; Xu W; Wang H; Tang T; Ma J; Cui Z; Shi H; Qin T; Zhou H; Li L; Jiang T; Li C
Biomed Pharmacother; 2022 Apr; 148():112742. PubMed ID: 35228063
[TBL] [Abstract][Full Text] [Related]
19. Artemisinin-type drugs for the treatment of hematological malignancies.
Mancuso RI; Foglio MA; Olalla Saad ST
Cancer Chemother Pharmacol; 2021 Jan; 87(1):1-22. PubMed ID: 33141328
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis.
Zhang Q; Yi H; Yao H; Lu L; He G; Wu M; Zheng C; Li Y; Chen S; Li L; Yu H; Li G; Tao X; Fu S; Deng X
J Cancer; 2021; 12(13):4075-4085. PubMed ID: 34093811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
